Assort Health Raises $120 Million in Series C Funding
Assort Health has successfully raised $120 million in a Series C funding round, aimed at advancing its AI voice agent technology within the healthcare sector. The funding, announced on June 24, 2026, was led by Menlo Ventures, with participation from Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Joe Montana, Tau Ventures, and Quiet Capital.
Company Overview
Founded by Jeffery L. and Jon Wang, who both serve as co-CEOs, Assort Health specializes in developing AI voice agents designed to streamline various healthcare processes. Their platform facilitates scheduling, patient intake, triage, referrals, and follow-up care across more than 22 medical specialties. The company boasts over 190 million patient interactions and claims that its solutions can be operational in a matter of weeks.
Strategic Use of Funds
The newly acquired capital will enable Assort Health to scale its AI platform, which supports healthcare organizations in transforming patient access and administrative workflows. The company plans to expand its AI-powered patient access solutions to health systems ranging from large community-based organizations to academic medical centers. This expansion aligns with the growing demand for platforms that can manage complex ambulatory operations.
Platform and Technology
Assort Health’s platform is built on a robust dataset comprising 62,000 care protocols and 1.6 million decision pathways. Its proprietary AI model, Synapse, is designed to learn and adapt to the unique patterns of specialty workflows, thereby enhancing the accuracy and efficiency of healthcare operations. The platform includes several products—Concierge, Activate, Orchestrate, and Empower—that collectively handle a wide array of tasks such as inbound calls, lab requests, medication refills, insurance eligibility checks, and more.
Leadership and Board Changes
As part of the funding round, JP Sanday from Menlo Ventures will join Assort Health’s Board of Directors, while Matt Murphy from the same firm will serve as a Board Observer. This addition to the board is expected to provide strategic guidance as Assort Health continues to grow its footprint in the healthcare sector.
Conclusion
With this significant investment, Assort Health is well-positioned to enhance its AI-driven solutions, aiming to improve the efficiency and effectiveness of healthcare services. As the company continues to innovate, it seeks to meet the increasing demand for advanced technological solutions in healthcare, thereby improving patient care and operational efficiency.